过去一年中添加的文章,按日期排序
[HTML][HTML] Inverse correlation between TP53 gene status and PD-L1 protein levels in a melanoma cell model depends on an IRF1/SOX10 regulatory axis
L Martinkova, P Zatloukalova… - Cellular & …, 2024 - cmbl.biomedcentral.com
1 天前 - … these two pathways and their effects on immune signaling. … into additional targeted
therapies for melanoma patients. … target genes that regulate multiple signaling pathways. To …
therapies for melanoma patients. … target genes that regulate multiple signaling pathways. To …
TICRR Overexpression Enhances Disease Aggressiveness and Immune Infiltration of Cutaneous Melanoma
C Chen, Y Zou, X Zheng, T Hu, J Ni, D Kan… - Pharmacogenomics …, 2024 - Taylor & Francis
4 天前 - … , the PI3K/AKT signalling pathway has been proven vital in … Citation2 BRAF-targeted
therapy has been applied in the … PI3K/AKT signalling pathway through the hyperactivation …
therapy has been applied in the … PI3K/AKT signalling pathway through the hyperactivation …
CD24 affects the immunosuppressive effect of tumor-infiltrating cells and tumor resistance in a variety of cancers
C Zhao, Y Huang, H Zhang, H Liu - Discover Oncology, 2024 - Springer
4 天前 - … and GSEA to compare biological signaling pathways between high and low CD24
… that melanoma patients with high CD24 expression were less responsive to PD-1 therapy. …
… that melanoma patients with high CD24 expression were less responsive to PD-1 therapy. …
[HTML][HTML] Basal Cell Carcinoma
MS Khalid, MA Jamil, A Shehzad, S Mazhar, F Hameed - 2024 - intechopen.com
5 天前 - … of skin cancer, the main one is the dysregulation in the Hedgehog signaling pathway
… of BCC; targeted therapy, that has increased the percentage of cure rate of the disease. …
… of BCC; targeted therapy, that has increased the percentage of cure rate of the disease. …
[HTML][HTML] Extract of Araçá-Boi and Its Major Phenolic Compound, Trans-Cinnamic Acid, Reduce Viability and Inhibit Migration of Human Metastatic Melanoma Cells
5 天前 - … signal-regulated kinase (MEK) signaling pathways [4,5]. Although the emergence
of immune and targeted therapies … life expectancy of patients with melanoma, some patients …
of immune and targeted therapies … life expectancy of patients with melanoma, some patients …
Involvement of the Δ133p53 isoform in the resistance of melanoma cell lines to targeted therapy
A Horvat, I Vlašić, A Tadijan, M Radić… - 19th International p53 …, 2024 - croris.hr
7 天前 - … leading to constitutive MEK and ERK signaling. In spite of initial … melanoma treatment.
Recently it was shown that the p53 pathway contributes to acquired resistance to targeted …
Recently it was shown that the p53 pathway contributes to acquired resistance to targeted …
USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization
P Biber, A Carminati, CA Girard, W Mohager… - bioRxiv, 2024 - biorxiv.org
7 天前 - … (DDR)/actomyosin signaling pathway. In silico analysis further … of melanoma cells
to targeted therapy (22,35,41). We first assessed the contribution of USP9X in melanoma cell …
to targeted therapy (22,35,41). We first assessed the contribution of USP9X in melanoma cell …
[HTML][HTML] Non-Muscle Myosin II A: Friend or Foe in Cancer?
W Feroz, BSY Park, M Siripurapu, N Ntim… - International Journal of …, 2024 - mdpi.com
8 天前 - … Therefore, in a melanoma mouse model, MYH9 may act as a potential tumor …
and targeted therapy by regulating the MAPK, PI3K/Akt, and Wnt/β-catenin signaling pathways. …
and targeted therapy by regulating the MAPK, PI3K/Akt, and Wnt/β-catenin signaling pathways. …
Modulating cancer stem cell characteristics in CD133+ melanoma cells through HIF1α, KLF4, and SHH silencing
H Aktug, B Ozdil, CB Avci, DC Kocaturk, V Gorgulu… - 2024 - researchsquare.com
8 天前 - … cells, followed by examination of the PI3K signaling pathway and Gli1/Gli3 expression
… speci c target therapies. In order to increase the metastatic capacity, melanoma cells …
… speci c target therapies. In order to increase the metastatic capacity, melanoma cells …
The role of ITIH5, a p53-regulated gene, in melanoma cell lines resistant to targeted therapy
I Vlašić, A Horvat, M Jazvinšćak Jembrek… - 19th International p53 …, 2024 - croris.hr
8 天前 - … signaling pathways. In order to determine the transcriptomic signature dependent
on the resistance to BRAFi targeted therapy and associated with p53 pathway… BRAFi therapy. …
on the resistance to BRAFi targeted therapy and associated with p53 pathway… BRAFi therapy. …